Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency

Antonio M. Almeida, Yoshiko Murakami, D. Mark Layton, Peter Hillmen, Gabrielle S. Sellick, Yusuke Maeda, Stephen Richards, Scott Patterson, Ioannis Kotsianidis, Luigina Mollica, Dorothy H. Crawford, Alastair Baker, Michael Ferguson, Irene Roberts, Richard Houlston, Taroh Kinoshita, Anastasios Karadimitris

    Research output: Contribution to journalArticlepeer-review

    187 Citations (Scopus)


    Attachment to the plasma membrane by linkage to a glycosylphosphatidylinositol (GPI) anchor¹ is a mode of protein expression highly conserved from protozoa to mammals². As a clinical entity, deficiency of GPI has been recognized as paroxysmal nocturnal hemoglobinuria, an acquired clonal disorder associated with somatic mutations of the X-linked PIGA gene in hematopoietic cells3,4. We have identified a novel disease characterized by a propensity to venous thrombosis and seizures in which deficiency of GPI is inherited in an autosomal recessive manner. In two unrelated kindreds, a point mutation (c?g) at position -270 from the start codon of PIGM, a mannosyltransferase-encoding gene, disrupts binding of the transcription factor Sp1 to its cognate promoter motif. This mutation substantially reduces transcription of PIGM and blocks mannosylation of GPI, leading to partial but severe deficiency of GPI. These findings indicate that biosynthesis of GPI is essential to maintain homeostasis of blood coagulation and neurological function.

    Original languageEnglish
    Pages (from-to)846-851
    Number of pages6
    JournalNature Medicine
    Issue number7
    Publication statusPublished - Jul 2006


    Dive into the research topics of 'Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency'. Together they form a unique fingerprint.

    Cite this